Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/FR2013/050557external-prioritypatent/WO2013140071A1/en
Application filed by Thea LabfiledCriticalThea Lab
Publication of TN2014000324A1publicationCriticalpatent/TN2014000324A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicinal Preparation
(AREA)
Abstract
La présente invention concerne une solution ophtalmique aqueuse comprenant un agent immunosuppresseur tel que la ciclosporine A et au moins trois polymères. Il s'agit avantageusement de la combinaison d'un dérivé cellulosique, d'un dérivé polyvinylique, et d'un hydroxystéarate de macrogolglycérol.The present invention relates to an aqueous ophthalmic solution comprising an immunosuppressive agent such as ciclosporin A and at least three polymers. It is advantageously a combination of a cellulose derivative, a polyvinyl derivative, and a macrogolglycerol hydroxystearate.
TNP2014000324A2012-03-222014-07-30
AQUEOUS OPHTHALMIC SOLUTION BASED ON CICLOSPORINE A
TN2014000324A1
(en)
Prophylactic and/or therapeutic agent for behavioral and psychological symptoms associated with neurodegenerative disease or impulsive symptoms associated with mental disease containing brexpiprazole or salt thereof.
PREPARATION OF (R) - AND (S) -N- (3,4-DIFLUORO-2- (2-FLUORO-4-IODOPHENYLAMINO) -6-METHOXYPHENYL) -1- (2,3-DIHYDROXYPROPYL) CYCLOPROPANE-1- SULFONAMIDE AND THEIR PROTECTED DERIVATIVES